Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2012
05/01/2012US8168308 Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element
05/01/2012CA2579087C Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
05/01/2012CA2509413C Benzazepine derivatives for the treatment of neurological disorders
05/01/2012CA2490722C Novel benzimidazole derivatives
04/2012
04/26/2012WO2012054698A1 Crystalline (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h-1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phthalazin-3(7h)-one tosylate salt
04/26/2012WO2012053606A1 Arylaminoheterocyclic carboxamide compound
04/26/2012WO2012053398A1 Organic electroluminescent element
04/26/2012WO2012053186A1 Arylamide derivatives as ttx-s blockers
04/26/2012WO2012052451A1 Metabotropic glutamate receptor modulators
04/26/2012WO2012051666A1 Organic electroluminescent device
04/26/2012WO2012024670A3 Composition and methods for treating glioblastoma
04/26/2012WO2012002680A3 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors
04/26/2012WO2011156786A3 6-(ethynyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
04/26/2012WO2011156640A3 8-(HETEROARYLMETHYL)PYRIDO[2,3-d]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS
04/26/2012WO2011058474A8 N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
04/26/2012WO2009156861A8 Substituted pyrimidone derivatives
04/26/2012US20120101280 Compound having spiro-bonded cyclic group and use thereof
04/26/2012US20120101124 1,2,4-oxadiazol derivatives, their pharmaceutical compositions and their use as sphingosine 1-phosphate 1 receptor agonists
04/26/2012US20120101123 Compounds
04/26/2012US20120101122 Imidazo[1,2 a] pyridine 6 carboxamide derivatives, their use for the treatment of colon cancer and their method of manufacture
04/26/2012US20120101121 drug demonstrating anxiolytic effect based on hydrogenated pyrido (4,3-b) indoles, its pharmacological compound and application method
04/26/2012US20120101115 Compounds For Inducing Cellular Apoptosis
04/26/2012US20120101110 Diaza-spiro[5.5]undecanes
04/26/2012US20120101106 Tetrahydronapthyridine Orexin Receptor Antagonists
04/26/2012US20120101097 Aryl sulfonamides
04/26/2012US20120101093 Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
04/26/2012US20120101086 Thiadiazole derivatives and their use for the treatment of disorders mediated by s1p1 receptors
04/26/2012US20120101064 Imidazole derivatives and their use as modulators of cyclin dependent kinases
04/26/2012US20120100628 Emissive and broadband nonlinear absorbing metal complexes and ligands as oled, optical switching or optical sensing materials
04/26/2012US20120100592 Pipemidic acid derivative autotaxin inhibitors
04/26/2012US20120100188 Solid state forms of paliperidone salts and process for the preparation thereof
04/26/2012DE102010049595A1 Chinazolinderivate Quinazoline derivatives
04/26/2012CA2814581A1 Crystalline (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h-1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phthalazin-3(7h)-one tosylate salt
04/26/2012CA2813994A1 Compounds, compositions and methods useful for cholesterol mobilisation
04/26/2012CA2813708A1 Arylamide derivatives as ttx-s blockers
04/25/2012EP2444402A1 Compound having spiro-bonded cyclic group and use thereof
04/25/2012EP2444401A1 Novel imidazopyridine compound
04/25/2012EP2444400A1 Substituted polycyclic carbamoylpyridone derivative
04/25/2012EP2444392A1 (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
04/25/2012EP2444120A1 Spirocyclic amiloride analogues as ENac blockers
04/25/2012EP2443122A1 Diazahomoadamantane derivatives and methods of use thereof
04/25/2012EP2443121A2 Gamma secretase modulators
04/25/2012EP2443120A2 New crystalline form of pemirolast
04/25/2012EP2443119A1 Gamma secretase modulators
04/25/2012EP2443118A1 Gamma secretase modulators
04/25/2012EP2443117A1 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
04/25/2012EP2443116A1 Thiadiazole derivatives and their use for the treatment of disorders mediated by slpl receptors
04/25/2012EP2443092A1 Bicyclic and tricyclic compounds as kat ii inhibitors
04/25/2012EP2279187B1 Spirocyclic derivatives as histone deacetylase inhibitors
04/25/2012EP2260023B1 Fluorene derivatives for organic electroluminescence devices
04/25/2012EP2247586B1 2-aza-bicyclo[2.2.1]heptane derivatives
04/25/2012EP2135870B1 Process for production of mirtazapine
04/25/2012EP2013207B1 Imidazo[4,5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
04/25/2012EP1888578B9 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo [4,5-c] quinolinyl)-phenyl]propionitrile as lipid kinase inhibitor
04/25/2012EP1804797B1 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
04/25/2012EP1719768B1 Novel benzothiazepine and benzothiepine compounds
04/25/2012CN102428084A 化合物 Compound
04/25/2012CN102427813A Novel anti-inflammatory agents
04/25/2012CN102424681A Acyl-tetrahydro-beta-carboline compound as well as derivatives, application and preparation method thereof
04/25/2012CN102424680A 病毒聚合酶抑制剂 Viral polymerase inhibitors
04/25/2012CN102423677A 一种合成长春胺中间体长春佛明专用反应釜 A synthetic Changchun Changchun Fermin dedicated amine intermediate reactor
04/25/2012CN102153551B 基于吲唑或氮杂吲唑的双芳基脲或硫脲类结构抗肿瘤药物 Bis-aryl urea or thiourea-based structure antineoplastic or aza-indazole indazole
04/25/2012CN101941990B Prodrugs of piperazine and substituted piperidine antiviral agents
04/25/2012CN101849953B 炎症性细胞因子产生游离抑制剂 Inflammatory cytokine production inhibitor free
04/25/2012CN101841005B New organic compound and organic light emitting device using the same
04/25/2012CN101812063B α-萘磺酰胺基五元杂环类化合物及其抑瘤活性 α- naphthalene sulfonamide five yuan heterocyclic compounds and Antitumor Activity
04/25/2012CN101775015B Synthesis method of phenanthroline-5,6-diketone
04/25/2012CN101747339B 1′-硫代氮杂靛玉红类化合物、用途及其制备方法 1'-aza Indirubin thiosulfate compounds, uses its preparation method
04/25/2012CN101426774B Azolecarboxamide derivative
04/25/2012CN101400680B 螺吲哚满酮衍生物 Spiro indolinone derivatives
04/24/2012US8163957 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
04/24/2012US8163921 Hepatitis C virus inhibitors
04/24/2012US8163919 Imidazopyridinyl benzamide mitotic kinesin inhibitors
04/24/2012US8163917 Azaindoles useful as inhibitors of Janus kinases
04/24/2012US8163915 Modulate neuronal nicotinic receptor activity; attention deficit disorder, Parkinson's, Tourette's, schizophrenia, cognitive deficits, dementia; acute pain, post-surgical pain, chronic pain, inflammatory pain; 1-azatricyclo[3.3.1.13,7]decan-4-one O-2-naphthyloxime
04/24/2012US8163914 Modulate neuronal nicotinic receptor activity; attention deficit disorder, Parkinson's, Tourette's, schizophrenia, cognitive deficits, dementia; acute pain, post-surgical pain, chronic pain, inflammatory pain; 2-[1-azatricyclo[3.3.1.13,7]dec-4-ylidene]-N-(4-methylphenyl)acetamide
04/24/2012US8163912 Berberine compounds and processes for the preparation of berberine compounds
04/24/2012US8163906 Dihydroquinone and dihydronaphthridine inhibitors of JNK
04/24/2012US8163769 1,8-naphthyridine derivatives
04/24/2012US8163768 4-(4-Hydroxy-3-methyl-phenyl)-2,4,6,7,8,9-hexahydro-pyrazolo[3,4-b]-1,7-naphthyridin-5-one; inhibiting Aurora kinase; inhibiting the proliferation of tumor cells; cancer, psoriasis, leukaemia and lupus
04/24/2012US8163767 Heterocyclic Janus Kinase 3 inhibitors
04/24/2012US8163763 Pyrimidine compounds, compositions and methods of use
04/24/2012US8163751 Acylated indanyl amines and their use as pharmaceuticals
04/24/2012US8163750 Fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone HSP 90
04/24/2012US8163737 CGRP receptor antagonists
04/24/2012US8163732 Tricyclic heteroaryl compounds useful as inhibitors of Janus kinase
04/24/2012CA2680783C Heterocyclic compounds and their uses
04/19/2012WO2012051450A1 Method of making azaindazole derivatives
04/19/2012WO2012051213A2 Therapeutic 5,6,5-tricyclic analogs
04/19/2012WO2012050764A1 Process for the preparation of cycloheptapyridine cgrp receptor antagonists
04/19/2012WO2011156780A3 8-(sulfonylbenzyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
04/19/2012WO2011156775A3 8-(2'-heterocycyl)pyrido[2.3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
04/19/2012WO2011156646A3 6-(sulfonylaryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
04/19/2012WO2011153157A3 Benzoquinolone inhibitors of vmat2
04/19/2012WO2011150156A3 Heteroaryl compounds and methods of use thereof
04/19/2012WO2011077098A9 Inhibitors of akt activity
04/19/2012US20120095233 Kinase inhibitors
04/19/2012US20120095217 Fluorine containing compounds and methods of use thereof
04/19/2012US20120095049 Nociceptin analogs
04/19/2012US20120095038 Synthesis and anti-proliferative effect of benzimidazole derivatives